Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsScientists reported that imatinib, an Abl tyrosine kinase inhibitor, robustly decreased SARS-CoV-2 infection and uncovered a mechanism of action.
[Scientific Reports]
Home Newsletters Immunology of Infectious Disease News Imatinib Inhibits SARS-CoV-2 Infection by an Off-Target-Mechanism
